For example, although Amazon.com... DALLAS, March 31, 2025--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Forte Biosciences (FBRX – Research Report). The company’s ...

FORTE BIOSCIENCES ($FBRX) is expected to release its quarterly earnings data on Monday, March 17th after market close, per Finnhub. Analysts are expecting revenue of ...